Both miRNAs have a crucial role in hemotoxicity: miRNA-1246 is upregulated to activate the expression of C6orf211 and C19orf10 to promote tumor progression [51], and miR-224 is impaired in the marrow of pediatric AML patients [52]. Here, DCPH1 is linked to neoplasm.